PL2968201T3 - Zwiększone dostarczanie leku z substancji klejących - Google Patents

Zwiększone dostarczanie leku z substancji klejących

Info

Publication number
PL2968201T3
PL2968201T3 PL14719442.7T PL14719442T PL2968201T3 PL 2968201 T3 PL2968201 T3 PL 2968201T3 PL 14719442 T PL14719442 T PL 14719442T PL 2968201 T3 PL2968201 T3 PL 2968201T3
Authority
PL
Poland
Prior art keywords
adhesives
drug delivery
enhanced drug
enhanced
delivery
Prior art date
Application number
PL14719442.7T
Other languages
English (en)
Inventor
Neal CARTY
Anne Marie WIBAUX
Original Assignee
Avery Dennison Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50549445&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2968201(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Avery Dennison Corporation filed Critical Avery Dennison Corporation
Publication of PL2968201T3 publication Critical patent/PL2968201T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
PL14719442.7T 2013-03-13 2014-03-13 Zwiększone dostarczanie leku z substancji klejących PL2968201T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361778620P 2013-03-13 2013-03-13
PCT/US2014/025184 WO2014159801A1 (en) 2013-03-13 2014-03-13 Enhanced drug delivery from adhesives

Publications (1)

Publication Number Publication Date
PL2968201T3 true PL2968201T3 (pl) 2023-05-15

Family

ID=50549445

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14719442.7T PL2968201T3 (pl) 2013-03-13 2014-03-13 Zwiększone dostarczanie leku z substancji klejących

Country Status (7)

Country Link
US (1) US20160022600A1 (pl)
EP (2) EP4162931A1 (pl)
KR (2) KR20220034252A (pl)
CN (1) CN105228598A (pl)
ES (1) ES2935743T3 (pl)
PL (1) PL2968201T3 (pl)
WO (1) WO2014159801A1 (pl)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
FR2738744B1 (fr) * 1995-09-20 1997-10-24 Oreal Patch cosmetique ou dermo-pharmaceutique contenant dans une matrice polymerique au moins un compose actif en particulier instable en milieu oxydant et au moins un agent hydro-absorbant
FR2761889B1 (fr) * 1997-04-11 1999-12-31 Oreal Patch pharmaceutique, cosmetique ou dermo-pharmaceutique pour la delivrance de plusieurs composes actifs de nature differente
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
ATE438418T1 (de) * 2001-05-01 2009-08-15 Av Topchiev Inst Petrochemical Hydrogel-zusammensetzungen
US20050202073A1 (en) * 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
CN101147739B (zh) * 2007-07-06 2010-12-08 北京康倍得医药技术开发有限公司 含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂
KR20090110255A (ko) * 2008-04-16 2009-10-21 닛토덴코 가부시키가이샤 약물 경피 투여 장치
US20090264806A1 (en) * 2008-04-16 2009-10-22 Kei Tamura Transdermal drug administration device
CN102144991A (zh) * 2010-02-08 2011-08-10 北京康倍得医药技术开发有限公司 含司来吉兰的组合物及含该组合物的透皮贴剂
CN101780205B (zh) * 2010-03-24 2011-08-10 安徽农业大学 用于治疗奶牛乳房炎的中药复方透皮贴剂及制备方法
WO2012092165A1 (en) * 2010-12-29 2012-07-05 Noven Pharmaceuticals, Inc. Transdermal drug delivery system comprising levonorgestrel acetate

Also Published As

Publication number Publication date
EP2968201B1 (en) 2022-12-28
KR20150131216A (ko) 2015-11-24
EP4162931A1 (en) 2023-04-12
US20160022600A1 (en) 2016-01-28
EP2968201A1 (en) 2016-01-20
CN105228598A (zh) 2016-01-06
KR102371530B1 (ko) 2022-03-04
ES2935743T3 (es) 2023-03-09
WO2014159801A1 (en) 2014-10-02
KR20220034252A (ko) 2022-03-17

Similar Documents

Publication Publication Date Title
HK1221672A1 (zh) 鼻腔給藥
HK1211517A1 (en) Drug delivery device
HK1211520A1 (en) Drug delivery device
IL245544A0 (en) drug delivery system
SG11201508647UA (en) Drug delivery device
EP2961469A4 (en) DEVICE FOR DELIVERY OF MEDICAMENT
HK1211519A1 (en) Drug delivery device
GB201313782D0 (en) Drug delivery device
HRP20180684T1 (hr) Kombinacija lijekova
IL244286A0 (en) Drug delivery device
EP4005604C0 (en) ADMINISTRATION OF MEDICINES
HK1216083A1 (zh) 經動脈的藥物遞送
SG11201600371XA (en) Drug delivery device
HK1219451A1 (zh) 藥物輸送裝置
GB201308917D0 (en) Delivery
ZA201507576B (en) Pharmaceutical combination drug
HK1219682A1 (zh) 藥物輸送裝置
HK1219685A1 (zh) 藥物輸送裝置
HK1219450A1 (zh) 藥物輸送裝置
HK1219681A1 (zh) 藥物輸送裝置
GB2519596B (en) Medicament Delivery device
HK1221921A1 (zh) 藥物輸送裝置
HK1219680A1 (zh) 藥物輸送裝置
HK1223052A1 (zh) 藥物輸送裝置
IL245007A0 (en) Drug release device